MyFinsight
Home
Blog
About
HAEMONETICS CORP (HAE)
HAEMONETICS CORP (HAE)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$44,417K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Share-based compensation expense
Change in prepaid income taxes
Others
Negative Cash Flow Breakdown
Payments on revolving credit fac...
Change in other assets and other...
Change in accounts payable and a...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-27
2026-03-28
2025-12-27
2025-09-27
Net income
33,010
-20,147
44,740
38,684
Depreciation and amortization
27,111
27,319
27,385
28,255
Amortization of fair value inventory step-up
0
0
1,323
2,055
Share-based compensation expense
9,311
9,127
7,799
7,589
Impairment of intangible assets
-
77,246
716
8,584
Gain on repurchase of convertible senior notes, net
-
0
0
0
Gains on sales of property, plant and equipment
-
178
218
75
Remeasurement of contingent consideration
-
-1,879
-
-
Deferred income taxes
668
-20,453
-2,062
-725
Other non-cash operating activities
2,227
5,975
2,072
865
Change in accounts receivable
-297
22,237
-11,058
7,259
Change in inventories
1,004
-8,462
-13,841
-21,762
Change in prepaid income taxes
-6,101
5,886
1,784
210
Change in other assets and other liabilities
12,783
6,730
4,610
5,903
Change in accounts payable and accrued expenses
-12,615
20,322
-6,696
17,699
Net cash provided by operating activities
52,323
70,941
93,564
111,321
Capital expenditures
7,906
17,661
6,349
5,016
Non-cash transfers from inventory to property, plant and equipment for haemonetics equipment
-5,565
-9,298
-13,444
-17,689
Acquisitions
-
60,180
0
0
Proceeds from divestiture and sale of assets
-
0
-
-
Proceeds from sale of property, plant and equipment
237
526
432
120
Other investments
9,000
0
10,105
7,883
Net cash used in investing activities
-22,234
-86,613
-29,466
-30,468
Proceeds from issuance of convertible notes
-
0
0
0
Repurchase of convertible senior notes
-
-
0
0
Repayment and repurchase of convertible notes
-
300,000
-
-
Purchase of capped call related to convertible notes
-
0
0
0
Term loan borrowings
-
0
0
0
Term loan redemption
-
0
0
0
Repayment of term loan borrowings
-
6,250
-
-
Proceeds from revolving facility
-
300,000
-
-
Payments on revolving credit facility
50,000
0
0
0
Repayment of term loan borrowings
-3,125
-
1,563
1,562
Debt issuance costs
-
0
0
0
Share repurchases
-
100,000
0
75,000
Proceeds from employee stock purchase plan
3,123
1,794
2,623
0
Proceeds from exercise of stock options
-1,246
-
1,147
63
Cash used to net share settle employee equity awards
3,500
46
160
14
Other financing activities
-14
-13
-14
-39
Net cash used in financing activities
-51,528
-101,499
2,033
-76,552
Effect of exchange rates on cash and cash equivalents
-617
-756
810
-773
Net change in cash and cash equivalents
-22,056
-117,927
66,941
3,528
Cash and cash equivalents at beginning of period
245,440
296,426
296,426
306,763
Cash and cash equivalents at end of period
223,384
245,440
363,367
296,426
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$33,010K
(-3.00%↓ Y/Y)
Depreciation and
amortization
$27,111K
(-5.73%↓ Y/Y)
Share-based compensation
expense
$9,311K
(-0.01%↓ Y/Y)
Change in prepaid
income taxes
-$6,101K
(-82.34%↓ Y/Y)
Other non-cash
operating activities
$2,227K
(22.77%↑ Y/Y)
Deferred income taxes
$668K
(120.67%↑ Y/Y)
Change in accounts
receivable
-$297K
(91.65%↑ Y/Y)
Net cash provided by
operating activities
$52,323K
(200.79%↑ Y/Y)
Canceled cashflow
$26,402K
Net change in cash
and cash...
-$22,056K
(-59.08%↓ Y/Y)
Canceled cashflow
$52,323K
Repayment of term loan
borrowings
-$3,125K
(-299.94%↓ Y/Y)
Proceeds from employee
stock purchase plan
$3,123K
(-10.16%↓ Y/Y)
Proceeds from sale of
property, plant and...
$237K
(-20.20%↓ Y/Y)
Change in other assets
and other...
$12,783K
(-28.12%↓ Y/Y)
Change in accounts
payable and accrued...
-$12,615K
(73.66%↑ Y/Y)
Change in inventories
$1,004K
(130.46%↑ Y/Y)
Net cash used in
financing activities
-$51,528K
(-2010.07%↓ Y/Y)
Canceled cashflow
$6,248K
Net cash used in
investing activities
-$22,234K
(32.62%↑ Y/Y)
Effect of exchange
rates on cash and cash...
-$617K
(-114.75%↓ Y/Y)
Canceled cashflow
$237K
Payments on revolving
credit facility
$50,000K
Cash used to net share
settle employee equity...
$3,500K
(-26.79%↓ Y/Y)
something is missing
-$3,016K
Proceeds from exercise of
stock options
-$1,246K
(-369.70%↓ Y/Y)
Other financing
activities
-$14K
(61.11%↑ Y/Y)
Other investments
$9,000K
(-50.23%↓ Y/Y)
Capital expenditures
$7,906K
(110.60%↑ Y/Y)
Non-cash transfers from
inventory to property,...
-$5,565K
(51.44%↑ Y/Y)
Buy us a coffee